arrow
F

Francisco Ojeda

university medical center hamburg—eppendorf
H指数:46
被引数:9,974

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Occurrence of Coronary Events in the Absence of Traditional Risk Factors: Understanding Residual Risk (Arnold et al. Biomarker-related coronary risk in the community)

在缺乏传统风险因素的情况下冠状动脉事件的发生:理解残余风险(Arnold等.社区中生物标志物相关的冠状动脉风险)

2025-08-090
OAAI
Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

脂蛋白(a)与社区中冠心病的发生:传统心血管危险因素的影响

2025-07-013
OAAI
Mobile integrons encode phage defense systems

移动整合子编码噬菌体防御系统

SCIENCE
IF45.8
2025-05-081
PRE
Serum Concentrations of Matrix Metalloproteinase-1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct-Like Myocarditis and Non-ST-Segment-Elevation Myocardial Infarction

血清基质金属蛋白酶-1和Ⅰ型前胶原羧基端肽的浓度可鉴别梗死样心肌炎与非ST段抬高型心肌梗死。

2024-07-161
OAAI
Prognostic Value of Cardiovascular Biomarkers in the Population

心血管生物标志物在人群中的预后价值

2024-06-1113
OA
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project
2024-01-1810
PRE
Unrecognized myocardial scar by late-gadolinium-enhancement cardiovascular magnetic resonance: Insights from the population-based Hamburg City Health Study
2024-01-010
OAAI
An arrhythmogenic metabolite in atrial fibrillation
2023-08-243
OAAI
Personalized diagnosis in suspected myocardial infarction
2023-05-0213
OAAI
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus
2023-04-205
PRE
Risk prediction of atrial fibrillation and its complications in the community using hs troponin I
2023-01-170
OA
Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods

使用回归和现代机器学习方法探索循环生物标志物对欧洲队列中房颤事件的稳健风险预测的增量效用

2023-01-0410
OAAI